SEC Form 4 · accession 0001127602-16-051626
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Massaro
Director
Period of report
May 9, 2016
Accepted (ET)
May 10, 2016 · 1:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 9, 2016 | S | 100 | $81.49 | D | 13,020 | D | |
| Common Stock | May 9, 2016 | S | 100 | $81.54 | D | 12,920 | D | |
| Common Stock | May 9, 2016 | S | 100 | $81.58 | D | 12,820 | D | |
| Common Stock | May 9, 2016 | S | 100 | $81.67 | D | 12,720 | D | |
| Common Stock | May 9, 2016 | S | 100 | $82.22 | D | 12,620 | D | |
| Common Stock | May 9, 2016 | S | 100 | $82.47 | D | 12,520 | D | |
| Common Stock | May 9, 2016 | S | 100 | $82.58 | D | 12,420 | D | |
| Common Stock | May 9, 2016 | S | 285 | $82.76 | D | 12,135 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.